apixaban
bms,pfizer
['apixaban']
dr. kovacs presenting the results of catheter 3 study (n=70) at #ash22
apixaban showing promise in cvc-associated uedvt in cancer patients with high preserved cvc function low risk of vte (1.4%) and bleeding complications (mb 2.9% and crnmb 5.7%). 